SLC25A12 Missense Variant in Nova Scotia Duck Tolling Retrievers Affected by Cerebellar Degeneration-Myositis Complex (CDMC).
Matthias ChristenStefan RuppIris Van SoensSofie F M BhattiKaspar MatiasekThilo von KlopmannVidhya JagannathanIndiana MaddenKevin L BatcherDanika L BannaschTosso LeebPublished in: Genes (2022)
We investigated two litters of distantly related Nova Scotia Duck Tolling Retrievers (NSDTR), of which four puppies were affected by cerebellar signs with or without neuromuscular weakness. The phenotype was termed cerebellar degeneration-myositis complex (CDMC). We suspected a heritable condition and initiated a genetic analysis. The genome of one affected dog was sequenced and compared to 565 control genomes. This search yielded a private protein-changing SLC25A12 variant in the affected dog, XM_038584842.1:c.1337C>T, predicted to result in the amino acid change XP_038440770.1:(p.Pro446Leu). The genotypes at the variant co-segregated with the phenotype as expected for a monogenic autosomal recessive mode of inheritance in both litters. Genotyping of 533 additional NSDTR revealed variant allele frequencies of 3.6% and 1.3% in a European and a North American cohort, respectively. The available clinical and biochemical data, together with current knowledge about SLC25A12 variants and their functional impact in humans, mice, and dogs, suggest the p.Pro446Leu variant is a candidate causative defect for the observed phenotype in the affected dogs.
Keyphrases
- amino acid
- healthcare
- intellectual disability
- genome wide
- interstitial lung disease
- anti inflammatory
- dna methylation
- pulmonary embolism
- single cell
- type diabetes
- autism spectrum disorder
- adipose tissue
- metabolic syndrome
- health insurance
- electronic health record
- duchenne muscular dystrophy
- muscular dystrophy
- data analysis
- genetic diversity